Methods, Biomarkers, and Future Directions in Neurology
Precision Neurology
From Syndromes to Endophenotypes
The future of neurology is increasingly defined by integrative phenotyping: imaging, genomics, transcriptomics, proteomics, electrophysiology, digital biomarkers, and longitudinal clinical data are combined to define biologically meaningful subtypes.
Modern Data Modalities
Genomics
- Identifies inherited risk, rare variants, and therapeutic targets
- Useful for monogenic, familial, and pleiotropic disorders
- Raises challenges in interpretation and penetrance
Digital phenotyping
- Uses wearables, speech, gait, and smartphone data
- Captures behavior outside clinic visits
- Can provide high-frequency longitudinal biomarkers
Frontier Methods
Which method is best suited to preserve both gene expression and tissue spatial context?
Spatial transcriptomics retains localization information while measuring gene expression.
Correct answer: Spatial transcriptomics
Why is causal inference important in neurologic biomarker research?
This distinction matters for diagnosis, prognosis, and therapeutic targeting.
Correct answer: It helps determine whether a biomarker is mechanistically related to disease or merely correlated with it.
Designing a Translational Neurology Study
-
1
Step 1: Define a clinically meaningful phenotype.
-
2
Step 2: Choose biomarkers aligned to the hypothesized biology.
-
3
Step 3: Establish longitudinal sampling and outcome measures.
-
4
Step 4: Validate findings across cohorts and modalities.
-
5
Step 5: Translate the model into diagnostic or therapeutic action.
What is the main advantage of multimodal biomarker panels over single tests?
Multimodal panels can integrate structure, function, and molecular state.
Correct answer: They can capture complementary biological processes
Open Problems Across Neurology
Outstanding problems include predicting conversion from preclinical disease to symptomatic neurodegeneration, defining robust surrogate endpoints, understanding brain resilience, and building interventions that modify disease before irreversible circuit loss.